GILEAD SCIENCES, INC.

GILD · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances) · Market Cap: $173.9B · 17,000 employees
145
SEC Filings
$138.99
Close 2026-04-10
7
Transcripts
17,000
Employees

Business Summary

Gilead Sciences, Inc. is a biopharmaceutical company that develops and commercializes medicines across therapeutic areas including HIV, viral hepatitis, oncology, and inflammatory diseases. Key products include BIKTARVY and DESCOVY (HIV), VEKLURY (COVID-19), EPCLUSA and HARVONI (hepatitis C), HEPCLUDEX (hepatitis B), TRODELVY and YESCARTA and TECARTUS (oncology), and LIVDELZI (liver disease).

Latest Stock Quote

GILD 2026-04-10 $138.99 O:$142.38 H:$142.38 L:$138.45 Vol:4.4M VWAP:$139.5544
origin leaf: 4ffdf651f94781e5940374a74517b2c38eaff11e7a86770928ce09b112be0f28

Next Earnings

Q2 FY2026 — expected 2026-08-09

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionGILDdiscussed Cybersecurity
topic_mentionGILDdiscussed Regulation
topic_mentionGILDdiscussed Regulation
topic_mentionGILDdiscussed Healthcare & Bio
topic_mentionGILDdiscussed Blockchain & Crypto
topic_mentionGILDdiscussed Regulation
topic_mentionGILDdiscussed Healthcare & Bio
topic_mentionGILDdiscussed Healthcare & Bio
topic_mentionGILDdiscussed Blockchain & Crypto
topic_mentionGILDdiscussed Regulation
topic_mentionGILDdiscussed Artificial Intelligence
topic_mentionGILDdiscussed Blockchain & Crypto
topic_mentionGILDdiscussed Regulation
topic_mentionGILDdiscussed Healthcare & Bio
topic_mentionGILDdiscussed Artificial Intelligence
topic_mentionGILDdiscussed Cybersecurity
topic_mentionGILDdiscussed Trusted Computing
topic_mentionGILDdiscussed Blockchain & Crypto
topic_mentionGILDdiscussed Semiconductor
topic_mentionGILDdiscussed Networking

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-242025-12-310000882095-26-000006EDGAR67K words
2025-02-282024-12-310000882095-25-000006EDGAR—
2024-02-232023-12-310000882095-24-000007EDGAR—
2023-02-222022-12-310000882095-23-000007EDGAR—
2022-02-232021-12-310000882095-22-000007EDGAR—
2021-02-252020-12-310000882095-21-000008EDGAR—
2020-02-252019-12-310000882095-20-000006EDGAR—
2019-02-262018-12-310000882095-19-000006EDGAR—
2018-02-272017-12-310000882095-18-000008EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-072025-09-300000882095-25-000047EDGAR40K words
2025-08-072025-06-300000882095-25-000032EDGAR—
2025-05-072025-03-310000882095-25-000012EDGAR—
2024-11-122024-09-300000882095-24-000028EDGAR—
2024-08-082024-06-300000882095-24-000022EDGAR—
2024-05-082024-03-310000882095-24-000013EDGAR—
2023-11-072023-09-300000882095-23-000031EDGAR—
2023-08-042023-06-300000882095-23-000025EDGAR—
2023-05-032023-03-310000882095-23-000017EDGAR—
2022-11-022022-09-300000882095-22-000027EDGAR—
2022-08-082022-06-300000882095-22-000019EDGAR—
2022-05-042022-03-310000882095-22-000013EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-02-230001104659-26-018314EDGAR61K words
2026-02-100000882095-26-000003EDGAR—
2025-11-190001104659-25-113968EDGAR—
2025-10-300000882095-25-000044EDGAR—
2025-10-060000882095-25-000041EDGAR—
2025-08-140000882095-25-000035EDGAR—
2025-08-070000882095-25-000030EDGAR—
2025-08-040000882095-25-000022EDGAR—
2025-05-080000882095-25-000015EDGAR—
2025-04-240000882095-25-000009EDGAR—

145 total filings indexed. 114 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Earnings Transcripts

Call DateQuarterTitle
— GILD Earnings Call Transcript
—Q4 FY2026GILD Q4 FY2026 Earnings Call Transcript
—Q4 FY2026GILD Q4 FY2026 Earnings Call Transcript
—Q4 FY2026GILD Q4 FY2026 Earnings Call Transcript
—Q4 FY2026GILD Q4 FY2026 Earnings Call Transcript
—Q4 FY2026GILD Q4 FY2026 Earnings Call Transcript
—Q4 FY2026GILD Q4 FY2026 Earnings Call Transcript

Access full transcripts via API (JSON) — includes speakers, key metrics, competitive mentions, and origin provenance chain.

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ABPO — Abpro Holdings, Inc.

Tags

hiv viral-hepatitis oncology inflammatory-diseases

Company Identity

CIK0000882095
TickerGILD
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedDE
Websitehttps://www.gilead.com
Listed1992-01-22

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: c46cb9d6ab74535a5a53061c1d4786e4afe17a70bc93a9f688277eae3b504a2f
parent: e72ea41f631853a6885af3aa610547fd13af566aff90e1272491d60835c762b8
content hash: f3d834587af8e9910e2ef819d55c75bdb795616edbdba1417b827b894e378e6f
signed: 2026-04-13T04:45:16.742Z
sources: 29 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf